Related Experiment Video

Updated: Jun 22, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Drug-induced liver injury: is it somehow foreseeable?

Giovanni Tarantino, Matteo Nicola Dario Di Minno, Domenico Capone

    World Journal of Gastroenterology
    |June 18, 2009
    PubMed

    Insights

    Drug-induced liver injury occurs when parent drug compounds become toxic through metabolism, primarily via cytochromes P-450 (CYP). Risk factors like genetics and health status can predict susceptibility, aiding physicians in diagnosis.

    Area of Science:

    • Pharmacology
    • Hepatology
    • Toxicology

    Background:

    • The traditional understanding of drug-induced liver injury (DILI) posits that parent drug compounds are metabolized into toxic neo-substances, primarily by cytochrome P-450 (CYP) enzymes.
    • Additional pathways, including mitochondrial dysfunction and apoptosis, contribute to the hepatotoxic effects of certain drugs.

    Discussion:

    • Risk factors for DILI encompass pre-existing hepatic conditions, patient age, and genetic variations in CYP enzymes.
    • Predictive capabilities for DILI susceptibility are advancing through phenotyping and genotyping studies, considering individual patient health status prior to drug administration.

    Key Insights:

    • Metabolism by cytochromes P-450 (CYP) is a key mechanism in the pathogenesis of drug-induced liver injury.
    • Genetic polymorphisms of CYP and patient health status are significant risk factors for DILI.
    • Early prediction of DILI susceptibility is becoming feasible through advanced patient assessment.

    Outlook:

    • Future research should focus on refining predictive models for DILI to enable personalized medicine approaches.
    • Continued investigation into the complex interplay of genetic, environmental, and health status factors is crucial for understanding DILI.
    • Addressing the ethical and legal implications for healthcare providers managing DILI is essential.

    More Related Videos

    Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube06:12

    Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

    Published on: April 28, 2020

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms11:36

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

    Published on: May 29, 2020

    Related Concept Videos

    Drug toxicity: Idiosyncratic Reactions01:16

    Drug toxicity: Idiosyncratic Reactions

    Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
    Drug Toxicity: Dose-Dependent Reactions01:24

    Drug Toxicity: Dose-Dependent Reactions

    Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
    Drug Toxicity: Risk factors01:24

    Drug Toxicity: Risk factors

    Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
    Drug Toxicity: Overview01:00

    Drug Toxicity: Overview

    Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...